公众号 / 文章神经骨肌MRSPECT

病例241:偏侧帕金森综合征-偏侧萎缩-99mTc TRODAT-1 SPECT与肌肉MR成像异常

Case 241: Hemiparkinsonism- Hemiatrophy-SPECT with 99mTc TRODAT-1 and Muscle MR Imaging Abnormalities.
PubMed 文献 · Radiology · 2017-01-01

43岁右利手男性,进行性左侧肢体无力及动作迟缓4年,查体见左侧偏身僵硬-运动不能综合征、面部表情减少及左侧肢体轻度萎缩。脑MRI各项序列均正常,遂行99mTc TRODAT-1 SPECT及肌肉MR成像进一步评估;左旋多巴/苄丝肼与金刚烷胺治疗改善不充分,UPDRS运动评分由23分降至20分。

要点

  • 偏侧帕金森综合征伴同侧肢体萎缩时,脑MRI常无基底节异常,需用多巴胺转运体SPECT及肌肉MR进一步评估。
  • 本例脑T1、T2、FLAIR、扩散/灌注加权及增强MR均正常,无基底节高信号、腔隙灶、钙化或重金属沉积。
  • 左旋多巴/苄丝肼(200/50 mg,每日4次)与金刚烷胺(100 mg,每日3次)治疗后UPDRS运动评分由23分降至20分,改善不充分。

核心结论

  • 43岁男性表现为左侧偏身僵硬-运动不能综合征伴左侧上、下肢轻度萎缩,脑MRI正常,采用99mTc TRODAT-1 SPECT与肌肉MR成像进一步评估;多巴胺能药物治疗后UPDRS运动评分由23分降至20分,改善不充分。

研究设计与样本

  • 病例报告:1例43岁右利手男性,表现为进行性左侧肢体无力及动作迟缓4年。
  • 评估手段包括脑MRI(T1、T2、FLAIR、扩散加权、灌注加权及增强序列)、肌肉MR成像及99mTc TRODAT-1 SPECT。
  • 临床量表:简易精神状态检查29/30分、蒙特利尔认知评估27/30分、UPDRS第III部分(运动检查)23/52分;肌力按医学研究委员会分级为4+/5。

关键影像表现/征象

  • 查体见左侧偏身僵硬-运动不能综合征、面部表情减少,左侧上、下肢轻度无力(肌力4+/5)。
  • 左侧上、下肢轻度萎缩,无疼痛、肿胀或皮肤病变。
  • 脑MRI各序列均正常,无基底节高信号、腔隙灶、钙化或重金属沉积。

临床应用与阅片要点

  • 对偏侧帕金森综合征伴同侧肢体萎缩者,脑MRI正常时原文采用99mTc TRODAT-1 SPECT及肌肉MR成像作进一步评估。
  • 本例左旋多巴/苄丝肼(200/50 mg,每日4次)与金刚烷胺(100 mg,每日3次)治疗后UPDRS运动评分由23分降至20分,改善不充分。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

History A 43-year-old right-handed man presented with a history of progressive mild left-sided weakness and slowness of movements. Symptoms began 4 years earlier, and the patient noticed a progressive decline in his daily routine due to gait difficulties in the past year. There was no history of head trauma, surgery, drug therapy, smoking, or alcohol abuse, nor was there any relevant family history. Examination revealed normal cognition (29 of 30 points on the Mini-Mental State Examination and 27 of 30 points on the Montreal Cognitive Assessment) and normal cerebellar, sensory, cranial nerve, and autonomic function. There was mild left-sided weakness involving the upper and lower limbs (medical research council graded muscle strength as 4+ out of 5) that was associated with facial hypomimia and a rigid akinetic syndrome only in the patient's left hemibody (Unified Parkinson's Disease Rating Scale [UPDRS] part III [motor examination], 23 out of 52 points). Mild atrophy in the left upper and lower limbs without pain, swelling, or skin lesions was noted at physical examination. Routine blood chemistry was normal, as were serum creatine kinase and aldolase levels and thyroid, hepatic, and renal function. T1- and T2-weighted, fluid-attenuated inversion recovery, diffusion- and perfusion-weighted, and contrast material-enhanced brain magnetic resonance (MR) imaging results were normal, without basal ganglia hyperintensity, lacunae, calcification, or heavy metal deposits. Muscle MR imaging and single photon emission computed tomography (SPECT) with technetium 99m (99mTc) tropane dopamine transporter (TRODAT)-1 were performed for further evaluation. This patient received levodopa and benserazide (200 and 50 mg, respectively) four times a day and amantadine (100 mg) three times a day without adequate improvement (UPDRS score decreased from 23 to 20 points).

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Vale TC, de Lima Pinto FC, Pedroso JL, et al. Case 241: Hemiparkinsonism- Hemiatrophy-SPECT with 99mTc TRODAT-1 and Muscle MR Imaging Abnormalities. Radiology. 2017. PMID: 28418820. doi:10.1148/radiol.2017151717

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。